Anaphylaxis

Last updated
Anaphylaxis
Angioedema2010.JPG
Facial angioedema in a young boy, leading to inability to open eyes. This reaction was caused by exposure to an allergen.
Specialty Allergy and immunology
Symptoms Itchy rash, throat swelling, numbness, shortness of breath, lightheadedness, low blood pressure [1]
Usual onsetOver minutes to hours [1]
TypesAnaphylactoid reaction, anaphylactic shock, biphasic anaphylaxis
CausesInsect bites, foods, medications [1]
Diagnostic method Based on symptoms [2]
Differential diagnosis Allergic reaction, angioedema, asthma exacerbation, carcinoid syndrome [2]
Treatment Epinephrine, intravenous fluids [1]
Frequency0.05–2% [3]

Anaphylaxis is a serious, potentially fatal allergic reaction and medical emergency that is rapid in onset and requires immediate medical attention regardless of use of emergency medication on site. [4] [5] It typically causes more than one of the following: an itchy rash, throat closing due to swelling that can obstruct or stop breathing; severe tongue swelling that can also interfere with or stop breathing; shortness of breath, vomiting, lightheadedness, loss of consciousness, low blood pressure, and medical shock. [6] [1] These symptoms typically start in minutes to hours and then increase very rapidly to life-threatening levels. [1] Urgent medical treatment is required to prevent serious harm and death, even if the patient has used an epipen or has taken other medications in response, and even if symptoms appear to be improving. [6]

Contents

Common causes include allergies to insect bites and stings, allergies to foods – including nuts, milk, fish, shellfish, eggs and some fresh fruits or dried fruits; allergies to sulfites – a class of food preservatives and a byproduct in some fermented foods like vinegar; allergies to medications – including some antibiotics and non-steroidal anti-inflammatory drugs (NSAIDs) like aspirin; allergy to general anaesthetic (used to make people sleep during surgery); allergy to contrast agents – dyes used in some medical tests to help certain areas of the body show up better on scans; allergy to latex – a type of rubber found in some rubber gloves and condoms. [6] [1] Other causes can include physical exercise, and cases may also occur in some people due to escalating reactions to simple throat irritation or may also occur without an obvious reason. [6] [1] The mechanism involves the release of inflammatory mediators in a rapidly escalating cascade from certain types of white blood cells triggered by either immunologic or non-immunologic mechanisms. [7] Diagnosis is based on the presenting symptoms and signs after exposure to a potential allergen or irritant and in some cases, reaction to physical exercise. [6] [1]

The primary treatment of anaphylaxis is epinephrine injection into a muscle, intravenous fluids, then placing the person "in a reclining position with feet elevated to help restore normal blood flow". [1] [8] Additional doses of epinephrine may be required. [1] Other measures, such as antihistamines and steroids, are complementary. [1] Carrying an epinephrine autoinjector, commonly called an "epipen" and identification regarding the condition is recommended in people with a history of anaphylaxis. [1] Immediately contacting ambulance / EMT services is always strongly recommended, regardless of any on site treatment. [6] Getting to a doctor or hospital as soon as possible is absolutely required in all cases, even if it appears to be getting better. [6]

Worldwide, 0.05–2% of the population is estimated to experience anaphylaxis at some point in life. [3] Globally, as underreporting declined into the 2010s, the rate appeared to be increasing. [3] It occurs most often in young people and females. [8] [9] About 99.7% of people hospitalized with anaphylaxis in the United States survive. [10]

Etymology

The word is derived from Ancient Greek : ἀνά , romanized: ana, lit.  'against', and φύλαξις romanized: phylaxis lit. 'protection'. [11]

Signs and symptoms

Signs and symptoms of anaphylaxis Signs and symptoms of anaphylaxis.svg
Signs and symptoms of anaphylaxis

Anaphylaxis typically presents many different symptoms over minutes or hours [8] [12] with an average onset of 5 to 30 minutes if exposure is intravenous and up to 2 hours if from eating food. [13] The most common areas affected include: skin (80–90%), respiratory (70%), gastrointestinal (30–45%), heart and vasculature (10–45%), and central nervous system (10–15%) [14] with usually two or more being involved. [3]

Skin

Urticaria and flushing on the chest of a person with anaphylaxis Rash on the chest of a person with anaphylaxis.jpg
Urticaria and flushing on the chest of a person with anaphylaxis

Symptoms typically include generalized hives, itchiness, flushing, or swelling (angioedema) of the affected tissues. [4] Those with angioedema may describe a burning sensation of the skin rather than itchiness. [13] Swelling of the tongue or throat occurs in up to about 20% of cases. [15] Other features may include a runny nose and swelling of the conjunctiva. [16] The skin may also be blue tinged because of lack of oxygen. [16]

Respiratory

Respiratory symptoms and signs that may be present include shortness of breath, wheezes, or stridor. [4] The wheezing is typically caused by spasms of the bronchial muscles [17] while stridor is related to upper airway obstruction secondary to swelling. [16] Hoarseness, pain with swallowing, or a cough may also occur. [13]

Cardiovascular

While a fast heart rate caused by low blood pressure is more common, [16] a Bezold–Jarisch reflex has been described in 10% of people, where a slow heart rate is associated with low blood pressure. [9] A drop in blood pressure or shock (either distributive or cardiogenic) may cause the feeling of lightheadedness or loss of consciousness. [17] Rarely very low blood pressure may be the only sign of anaphylaxis. [15]

Coronary artery spasm may occur with subsequent myocardial infarction, dysrhythmia, or cardiac arrest. [3] [14] Those with underlying coronary disease are at greater risk of cardiac effects from anaphylaxis. [17] The coronary spasm is related to the presence of histamine-releasing cells in the heart. [17]

Other

Gastrointestinal symptoms may include severe crampy abdominal pain, diarrhea[ failed verification ], and vomiting. [4] There may be confusion, a loss of bladder control or pelvic pain similar to that of uterine cramps. [4] [16] Dilation of blood vessels around the brain may cause headaches. [13] A feeling of anxiety or of "impending doom" has also been described. [3]

Causes

Anaphylaxis can occur in response to almost any foreign substance. [18] Common triggers include venom from insect bites or stings, foods, and medication. [9] [19] Foods are the most common trigger in children and young adults, while medications and insect bites and stings are more common in older adults. [3] Less common causes include: physical factors, biological agents such as semen, latex, hormonal changes, food additives and colors, and topical medications. [16] Physical factors such as exercise (known as exercise-induced anaphylaxis) or temperature (either hot or cold) may also act as triggers through their direct effects on mast cells. [3] [20] [21] Events caused by exercise are frequently associated with cofactors such as the ingestion of certain foods [13] [22] or taking an NSAID. [22] In aspirin-exacerbated respiratory disease (AERD), alcohol is a common trigger. [23] [24] During anesthesia, neuromuscular blocking agents, antibiotics, and latex are the most common causes. [25] The cause remains unknown in 32–50% of cases, referred to as "idiopathic anaphylaxis." [26] Six vaccines (MMR, varicella, influenza, hepatitis B, tetanus, meningococcal) are recognized as a cause for anaphylaxis, and HPV may cause anaphylaxis as well. [27]

Food and alcohol

Many foods can trigger anaphylaxis; this may occur upon the first known ingestion. [9] Common triggering foods vary around the world due to cultural cuisine. In Western cultures, ingestion of or exposure to peanuts, wheat, nuts, certain types of seafood like shellfish, milk, fruit and eggs are the most prevalent causes. [3] [14] Sesame is common in the Middle East, while rice and chickpeas are frequently encountered as sources of anaphylaxis in Asia. [3] Severe cases are usually caused by ingesting the allergen, [9] but some people experience a severe reaction upon contact. Children can outgrow their allergies. By age 16, 80% of children with anaphylaxis to milk or eggs and 20% who experience isolated anaphylaxis to peanuts can tolerate these foods. [18] Any type of alcohol, even in small amounts, can trigger anaphylaxis in people with AERD. [23] [24]

Medication

Any medication may potentially trigger anaphylaxis. The most common are β-lactam antibiotics (such as penicillin) followed by aspirin and NSAIDs. [14] [28] Other antibiotics are implicated less frequently. [28] Anaphylactic reactions to NSAIDs are either agent specific or occur among those that are structurally similar meaning that those who are allergic to one NSAID can typically tolerate a different one or different group of NSAIDs. [29] Other relatively common causes include chemotherapy, vaccines, protamine and herbal preparations. [3] Some medications (vancomycin, morphine, x-ray contrast among others) cause anaphylaxis by directly triggering mast cell degranulation. [9]

The frequency of a reaction to an agent partly depends on the frequency of its use and partly on its intrinsic properties. [30] Anaphylaxis to penicillin or cephalosporins occurs only after it binds to proteins inside the body with some agents binding more easily than others. [13] Anaphylaxis to penicillin occurs once in every 2,000 to 10,000 courses of treatment, with death occurring in fewer than one in every 50,000 courses of treatment. [13] Anaphylaxis to aspirin and NSAIDs occurs in about one in every 50,000 persons. [13] If someone has a reaction to penicillin, his or her risk of a reaction to cephalosporins is greater but still less than one in 1,000. [13] The old radiocontrast agents caused reactions in 1% of cases, while the newer lower osmolar agents cause reactions in 0.04% of cases. [30]

Venom

Venom from stinging or biting insects such as Hymenoptera (ants, bees, and wasps) or Triatominae (kissing bugs) may cause anaphylaxis in susceptible people. [8] [31] [32] Previous reactions that are anything more than a local reaction around the site of the sting, are a risk factor for future anaphylaxis; [33] [34] however, half of fatalities have had no previous systemic reaction. [35]

Risk factors

People with atopic diseases such as asthma, eczema, or allergic rhinitis are at high risk of anaphylaxis from food, latex, and radiocontrast agents but not from injectable medications or stings. [3] [9] One study in children found that 60% had a history of previous atopic diseases, and of children who die from anaphylaxis, more than 90% have asthma. [9] Those with mastocytosis or of a higher socioeconomic status are at increased risk. [3] [9]

Pathophysiology

Anaphylaxis is a severe allergic reaction of rapid onset affecting many body systems. [5] [7] It is due to the release of inflammatory mediators and cytokines from mast cells and basophils, typically due to an immunologic reaction but sometimes non-immunologic mechanism. [7]

Interleukin (IL)–4 and IL-13 are cytokines important in the initial generation of antibody and inflammatory cell responses to anaphylaxis.[ citation needed ]

Immunologic

In the immunologic mechanism, immunoglobulin E (IgE) binds to the antigen (the foreign material that provokes the allergic reaction). Antigen-bound IgE then activates FcεRI receptors on mast cells and basophils. This leads to the release of inflammatory mediators such as histamine. These mediators subsequently increase the contraction of bronchial smooth muscles, trigger vasodilation, increase the leakage of fluid from blood vessels, and cause heart muscle depression. [7] [13] There is also a non-immunologic mechanism that does not rely on IgE, but it is not known if this occurs in humans. [7]

Non-immunologic

Non-immunologic mechanisms involve substances that directly cause the degranulation of mast cells and basophils. These include agents such as contrast medium, opioids, temperature (hot or cold), and vibration. [7] [20] Sulfites may cause reactions by both immunologic and non-immunologic mechanisms. [36]

Diagnosis

Anaphylaxis is diagnosed on the basis of a person's signs and symptoms. [3] When any one of the following three occurs within minutes or hours of exposure to an allergen there is a high likelihood of anaphylaxis: [3]

  1. Involvement of the skin or mucosal tissue plus either respiratory difficulty or a low blood pressure causing symptoms
  2. Two or more of the following symptoms after a likely contact with an allergen:
    a. Involvement of the skin or mucosa
    b. Respiratory difficulties
    c. Low blood pressure
    d. Gastrointestinal symptoms
  3. Low blood pressure after exposure to a known allergen

Skin involvement may include: hives, itchiness or a swollen tongue among others. Respiratory difficulties may include: shortness of breath, stridor, or low oxygen levels among others. Low blood pressure is defined as a greater than 30% decrease from a person's usual blood pressure. In adults a systolic blood pressure of less than 90 mmHg is often used. [3]

During an attack, blood tests for tryptase or histamine (released from mast cells) might be useful in diagnosing anaphylaxis due to insect stings or medications. However these tests are of limited use if the cause is food or if the person has a normal blood pressure, [3] and they are not specific for the diagnosis. [18]

Classification

There are three main classifications of anaphylaxis.

  1. Anaphylactic shock is associated with systemic vasodilation that causes low blood pressure which is by definition 30% lower than the person's baseline or below standard values. [15]
  2. Biphasic anaphylaxis is the recurrence of symptoms within 1–72 hours after resolution of an initial anaphylactic episode. [37] Estimates of incidence vary, between less than 1% and up to 20% of cases. [37] [38] The recurrence typically occurs within 8 hours. [9] It is managed in the same manner as anaphylaxis. [8]
  3. Anaphylactoid reaction, non-immune anaphylaxis, or pseudoanaphylaxis, is a type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation. [9] [39] Non-immune anaphylaxis is the current term, as of 2018, used by the World Allergy Organization [39] with some recommending that the old terminology, "anaphylactoid", no longer be used. [9]

Allergy skin testing

Skin allergy testing being carried out on the right arm Allergy skin testing.JPG
Skin allergy testing being carried out on the right arm
Patch test Epikutanni-test.jpg
Patch test

Allergy testing may help in determining the trigger. Skin allergy testing is available for certain foods and venoms. [18] Blood testing for specific IgE can be useful to confirm milk, egg, peanut, tree nut and fish allergies. [18]

Skin testing is available to confirm penicillin allergies, but is not available for other medications. [18] Non-immune forms of anaphylaxis can only be determined by history or exposure to the allergen in question, and not by skin or blood testing. [39]

Differential diagnosis

It can sometimes be difficult to distinguish anaphylaxis from asthma, syncope, and panic attacks. [3] Asthma however typically does not entail itching or gastrointestinal symptoms, syncope presents with pallor rather than a rash, and a panic attack may have flushing but does not have hives. [3] Other conditions that may present similarly include: scrombroidosis and anisakiasis. [9]

Post-mortem findings

In a person who died from anaphylaxis, autopsy may show an "empty heart" attributed to reduced venous return from vasodilation and redistribution of intravascular volume from the central to the peripheral compartment. [40] Other signs are laryngeal edema, eosinophilia in lungs, heart and tissues, and evidence of myocardial hypoperfusion. [41] Laboratory findings could detect increased levels of serum tryptase, increase in total and specific IgE serum levels. [41]

Prevention

Avoidance of the trigger of anaphylaxis is recommended. In cases where this may not be possible, desensitization may be an option.Immunotherapy with Hymenoptera venoms is effective at desensitizing 80–90% of adults and 98% of children against allergies to bees, wasps, hornets, yellowjackets, and fire ants. Oral immunotherapy may be effective at desensitizing some people to certain food including milk, eggs, nuts and peanuts; however, adverse effects are common. [3] For example, many people develop an itchy throat, cough, or lip swelling during immunotherapy. [42] Desensitization is also possible for many medications, however it is advised that most people simply avoid the agent in question. In those who react to latex it may be important to avoid cross-reactive foods such as avocados, bananas, and potatoes among others. [3]

Management

Anaphylaxis is a medical emergency that may require resuscitation measures such as airway management, supplemental oxygen, large volumes of intravenous fluids, and close monitoring. [8] Passive leg raise may also be helpful in the emergency management. [43]

Administration of intravenous fluid bolus and epinephrine is the treatment of choice with antihistamines used as adjuncts. [44] A period of in-hospital observation for between 2 and 24 hours is recommended for people once they have returned to normal due to concerns of biphasic anaphylaxis. [9] [13] [38] [45]

Epinephrine

An old version of an EpiPen brand auto-injector Epipen.jpg
An old version of an EpiPen brand auto-injector

Epinephrine (adrenaline) (1 in 1,000) is the primary treatment for anaphylaxis with no absolute contraindication to its use. [8] It is recommended that an epinephrine solution be given intramuscularly into the mid anterolateral thigh as soon as the diagnosis is suspected. The injection may be repeated every 5 to 15 minutes if there is insufficient response. [8] A second dose is needed in 16–35% of episodes with more than two doses rarely required. [8] The intramuscular route is preferred over subcutaneous administration because the latter may have delayed absorption. [8] [46] It is recommended that after diagnosis and treatment of anaphylaxis, the patient should be kept under observation in an appropriate clinical setting until symptoms have fully resolved. [37] Minor adverse effects from epinephrine include tremors, anxiety, headaches, and palpitations. [3]

People on β-blockers may be resistant to the effects of epinephrine. [9] In this situation if epinephrine is not effective intravenous glucagon can be administered which has a mechanism of action independent of β-receptors. [9]

If necessary, it can also be given intravenously using a dilute epinephrine solution. Intravenous epinephrine, however, has been associated both with dysrhythmia and myocardial infarction. [8] Epinephrine autoinjectors used for self-administration typically come in two doses, one for adults or children who weigh more than 25 kg and one for children who weigh 10 to 25 kg. [47]

Adjuncts

Antihistamines (both H1 and H2), while commonly used and assumed effective based on theoretical reasoning, are poorly supported by evidence. [48] [49] A 2007 Cochrane review did not find any good-quality studies upon which to base recommendations [49] and they are not believed to have an effect on airway edema or spasm. [9] Corticosteroids are unlikely to make a difference in the current episode of anaphylaxis, but may be used in the hope of decreasing the risk of biphasic anaphylaxis. Their prophylactic effectiveness in these situations is uncertain. [38] Nebulized salbutamol may be effective for bronchospasm that does not resolve with epinephrine. [9] Methylene blue has been used in those not responsive to other measures due to its presumed effect of relaxing smooth muscle. [9]

Preparedness

People prone to anaphylaxis are advised to have an allergy action plan. Parents are advised to inform schools of their children's allergies and what to do in case of an anaphylactic emergency. The action plan usually includes use of epinephrine autoinjectors, the recommendation to wear a medical alert bracelet, and counseling on avoidance of triggers. [50] Immunotherapy is available for certain triggers to prevent future episodes of anaphylaxis. A multi-year course of subcutaneous desensitization has been found effective against stinging insects, while oral desensitization is effective for many foods. [14]

Prognosis

In those in whom the cause is known and prompt treatment is available, the prognosis is good. [51] Even if the cause is unknown, if appropriate preventive medication is available, the prognosis is generally good. [13] Usually death occurs due to either respiratory failure (typically involving asphyxia) or cardiovascular complications, such as cardiovascular shock, [7] [9] with 0.7–20% of cases causing death. [13] [17] There have been cases of death occurring within minutes. [3] Outcomes in those with exercise-induced anaphylaxis are typically good, with fewer and less severe episodes as people get older. [26]

Epidemiology

The number of people who get anaphylaxis is 4–100 per 100,000 persons per year, [9] [52] with a lifetime risk of 0.05–2%. [53] About 30% of people get more than one attack. [52] Exercise-induced anaphylaxis affects about 1 in 2000 young people. [22]

Rates appear to be increasing: the numbers in the 1980s were approximately 20 per 100,000 per year, while in the 1990s it was 50 per 100,000 per year. [14] The increase appears to be primarily for food-induced anaphylaxis. [54] The risk is greatest in young people and females. [8] [9]

Anaphylaxis leads to as many as 500–1,000 deaths per year (2.7 per million) in the United States, 20 deaths per year in the United Kingdom (0.33 per million), and 15 deaths per year in Australia (0.64 per million). [9] Another estimate from the United States puts the death rate at 0.7 per million. [55] Mortality rates have decreased between the 1970s and 2000s. [56] In Australia, death from food-induced anaphylaxis occur primarily in women while deaths due to insect bites primarily occur in males. [9] Death from anaphylaxis is most commonly triggered by medications. [9]

History

The conditions of anaphylaxis has been known since ancient times. [39] French physician François Magendie had described how rabbits were killed by repeated injections of egg albumin in 1839. [57] However, the phenomenon was discovered by two French physiologists Charles Richet and Paul Portier. [58] In 1901, Albert I, Prince of Monaco requested Richet and Portier join him on a scientific expedition around the French coast of the Atlantic Ocean, [59] specifically to study on the toxin produced by cnidarians (like jellyfish and sea anemones). [58] Richet and Portier boarded Albert's ship Princesse Alice II for ocean exploration to make collections of the marine animals. [60]

Richet and Portier extracted a toxin called hypnotoxin from their collection of jellyfish (but the real source was later identified as Portuguese man o' war) [61] and sea anemone ( Actinia sulcata ). [62] In their first experiment on the ship, they injected a dog with the toxin in an attempt to immunise the dog, which instead developed a severe reaction (hypersensitivity). In 1902, they repeated the injections in their laboratory and found that dogs normally tolerated the toxin at first injection, but on re-exposure, three weeks later with the same dose, they always developed fatal shock. They also found that the effect was not related to the doses of toxin used, as even small amounts in secondary injections were lethal. [62] Thus, instead of inducing tolerance (prophylaxis) which they expected, they discovered effects of the toxin as deadly. [63]

In 1902, Richet introduced the term aphylaxis to describe the condition of lack of protection. He later changed the term to anaphylaxis on grounds of euphony. [18] The term is from the Greek ἀνά-, ana-, meaning "against", and φύλαξις, phylaxis, meaning "protection". [64] On 15 February 1902, Richet and Portier jointly presented their findings before the Societé de Biologie in Paris. [65] [66] The moment is regarded as the birth of allergy (the term invented by Clemens von Pirquet in 1906) study (allergology). [66] Richet continued to study on the phenomenon and was eventually awarded the Nobel Prize in Physiology or Medicine for his work on anaphylaxis in 1913. [60] [67]

Research

There are ongoing efforts to develop sublingual epinephrine to treat anaphylaxis. Trials of sublingual epinephrine, currently called AQST-108 (dipivefrin) and sponsored by Aquestive Therapeutics, are in phase 1 trials as of December 2021. [9] [68] Subcutaneous injection of the anti-IgE antibody omalizumab is being studied as a method of preventing recurrence, but it is not yet recommended.[ needs update ] [3] [69]

Related Research Articles

<span class="mw-page-title-main">Allergy</span> Immune system response to a substance that most people tolerate well

Allergies, also known as allergic diseases, are various conditions caused by hypersensitivity of the immune system to typically harmless substances in the environment. These diseases include hay fever, food allergies, atopic dermatitis, allergic asthma, and anaphylaxis. Symptoms may include red eyes, an itchy rash, sneezing, coughing, a runny nose, shortness of breath, or swelling. Note that food intolerances and food poisoning are separate conditions.

<span class="mw-page-title-main">Food allergy</span> Hypersensitivity reaction to a food

A food allergy is an abnormal immune response to food. The symptoms of the allergic reaction may range from mild to severe. They may include itchiness, swelling of the tongue, vomiting, diarrhea, hives, trouble breathing, or low blood pressure. This typically occurs within minutes to several hours of exposure. When the symptoms are severe, it is known as anaphylaxis. A food intolerance and food poisoning are separate conditions, not due to an immune response.

<span class="mw-page-title-main">Type I hypersensitivity</span> Type of allergic reaction

Type I hypersensitivity, in the Gell and Coombs classification of allergic reactions, is an allergic reaction provoked by re-exposure to a specific type of antigen referred to as an allergen. Type I is distinct from type II, type III and type IV hypersensitivities. The relevance of the Gell and Coombs classification of allergic reactions has been questioned in the modern-day understanding of allergy, and it has limited utility in clinical practice.

<span class="mw-page-title-main">Allergen immunotherapy</span> Medical treatment for environmental allergies

Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for environmental allergies, such as insect bites, and asthma. Immunotherapy involves exposing people to larger and larger amounts of allergens in an attempt to change the immune system's response.

<span class="mw-page-title-main">Peanut allergy</span> Type of food allergy caused by peanuts

Peanut allergy is a type of food allergy to peanuts. It is different from tree nut allergies, because peanuts are legumes and not true nuts. Physical symptoms of allergic reaction can include itchiness, hives, swelling, eczema, sneezing, asthma attack, abdominal pain, drop in blood pressure, diarrhea, and cardiac arrest. Anaphylaxis may occur. Those with a history of asthma are more likely to be severely affected.

<span class="mw-page-title-main">Soy allergy</span> Type of food allergy caused by soy

Soy allergy is a type of food allergy. It is a hypersensitivity to ingesting compounds in soy, causing an overreaction of the immune system, typically with physical symptoms, such as gastrointestinal discomfort, respiratory distress, or a skin reaction. Soy is among the eight most common foods inducing allergic reactions in children and adults. It has a prevalence of about 0.3% in the general population.

<span class="mw-page-title-main">Milk allergy</span> Type of food allergy caused by milk

Milk allergy is an adverse immune reaction to one or more proteins in cow's milk. Symptoms may take hours to days to manifest, with symptoms including atopic dermatitis, inflammation of the esophagus, enteropathy involving the small intestine and proctocolitis involving the rectum and colon. However, rapid anaphylaxis is possible, a potentially life-threatening condition that requires treatment with epinephrine, among other measures.

<span class="mw-page-title-main">Egg allergy</span> Type of food allergy caused by eggs

Egg allergy is an immune hypersensitivity to proteins found in chicken eggs, and possibly goose, duck, or turkey eggs. Symptoms can be either rapid or gradual in onset. The latter can take hours to days to appear. The former may include anaphylaxis, a potentially life-threatening condition which requires treatment with epinephrine. Other presentations may include atopic dermatitis or inflammation of the esophagus.

<span class="mw-page-title-main">Tree nut allergy</span> Medical condition

A tree nut allergy is a hypersensitivity to dietary substances from tree nuts and edible tree seeds causing an overreaction of the immune system which may lead to severe physical symptoms. Tree nuts include almonds, Brazil nuts, cashews, chestnuts, filberts/hazelnuts, macadamia nuts, pecans, pistachios, shea nuts and walnuts.

A drug allergy is an allergy to a drug, most commonly a medication, and is a form of adverse drug reaction. Medical attention should be sought immediately if an allergic reaction is suspected.

One of the most prevalent forms of adverse drug reactions is cutaneous reactions, with drug-induced urticaria ranking as the second most common type, preceded by drug-induced exanthems. Urticaria, commonly known as hives, manifests as weals, itching, burning, redness, swelling, and angioedema—a rapid swelling of lower skin layers, often more painful than pruritic. These symptoms may occur concurrently, successively, or independently. Typically, when a drug triggers urticaria, symptoms manifest within 24 hours of ingestion, aiding in the identification of the causative agent. Urticaria symptoms usually subside within 1–24 hours, while angioedema may take up to 72 hours to resolve completely.

Allergy testing can help confirm or rule out allergies and consequently reduce adverse reactions and limit unnecessary avoidance and medications.

Pseudoallergy, sometimes known as nonallergic hypersensitivity, is a clinical mimic of immediate-type allergic reactions that lacks underlying immunological mechanisms.

Mast cell activation syndrome (MCAS) is a term referring to one of two types of mast cell activation disorder (MCAD); the other type is idiopathic MCAD. MCAS is an immunological condition in which mast cells inappropriately and excessively release chemical mediators, resulting in a range of chronic symptoms, sometimes including anaphylaxis or near-anaphylaxis attacks. Primary symptoms include cardiovascular, dermatological, gastrointestinal, neurological and respiratory problems.

<span class="mw-page-title-main">Epinephrine (medication)</span> Hormone used as a medicine

Epinephrine, also known as adrenaline, is a medication and hormone. As a medication, it is used to treat several conditions, including anaphylaxis, cardiac arrest, asthma, and superficial bleeding. Inhaled epinephrine may be used to improve the symptoms of croup. It may also be used for asthma when other treatments are not effective. It is given intravenously, by injection into a muscle, by inhalation, or by injection just under the skin.

<span class="mw-page-title-main">Allergies in children</span> Medical condition

Allergies in children, an incidence which has increased over the last fifty years, are overreactions of the immune system often caused by foreign substances or genetics that may present themselves in different ways. There are multiple forms of testing, prevention, management, and treatment available if an allergy is present in a child. In some cases, it is possible for children to outgrow their allergies.

Exercise-induced anaphylaxis is a rare condition in which anaphylaxis, a serious or life-threatening allergic response, is brought on by physical activity. Approximately 5–15% of all reported cases of anaphylaxis are thought to be exercise-induced.

<span class="mw-page-title-main">Fish allergy</span> Type of food allergy caused by fish

Fish allergy is an immune hypersensitivity to proteins found in fish. Symptoms can be either rapid or gradual in onset. The latter can take hours to days to appear. The former may include anaphylaxis, a potentially life-threatening condition which requires treatment with epinephrine. Other presentations may include atopic dermatitis or inflammation of the esophagus. Fish is one of the eight common food allergens which are responsible for 90% of allergic reactions to foods: cow's milk, eggs, wheat, shellfish, peanuts, tree nuts, fish, and soy beans.

<span class="mw-page-title-main">Shellfish allergy</span> Type of food allergy caused by shellfish

Shellfish allergy is among the most common food allergies. "Shellfish" is a colloquial and fisheries term for aquatic invertebrates used as food, including various species of molluscs such as clams, mussels, oysters and scallops, crustaceans such as shrimp, lobsters and crabs, and cephalopods such as squid and octopus. Shellfish allergy is an immune hypersensitivity to proteins found in shellfish. Symptoms can be either rapid or gradual in onset. The latter can take hours to days to appear. The former may include anaphylaxis, a potentially life-threatening condition which requires treatment with epinephrine. Other presentations may include atopic dermatitis or inflammation of the esophagus. Shellfish is one of the eight common food allergens, responsible for 90% of allergic reactions to foods: cow's milk, eggs, wheat, shellfish, peanuts, tree nuts, fish, and soy beans.

<span class="mw-page-title-main">Sesame allergy</span> Food allergy caused by sesame seeds

A food allergy to sesame seeds has prevalence estimates in the range of 0.1–0.2% of the general population, and are higher in the Middle East and other countries where sesame seeds are used in traditional foods. Reporting of sesame seed allergy has increased in the 21st century, either due to a true increase from exposure to more sesame foods or due to an increase in awareness. Increasing sesame allergy rates have induced more countries to regulate food labels to identify sesame ingredients in products and the potential for allergy. In the United States, sesame became the ninth food allergen with mandatory labeling, effective 1 January 2023.

References

  1. 1 2 3 4 5 6 7 8 9 10 11 12 13 "Anaphylaxis". National Institute of Allergy and Infectious Diseases. April 23, 2015. Archived from the original on 4 May 2015. Retrieved 4 February 2016.
  2. 1 2 Caterino JM, Kahan S (2003). In a Page: Emergency medicine. Lippincott Williams & Wilkins. p. 132. ISBN   9781405103572. Archived from the original on 2017-09-08.
  3. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Simons FE, Ardusso LR, Bilò MB, El-Gamal YM, Ledford DK, Ring J, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY, World Allergy O (February 2011). "World allergy organization guidelines for the assessment and management of anaphylaxis". The World Allergy Organization Journal. 4 (2): 13–37. doi:10.1097/wox.0b013e318211496c. PMC   3500036 . PMID   23268454.
  4. 1 2 3 4 5 Sampson HA, Muñoz-Furlong A, Campbell RL, et al. (February 2006). "Second symposium on the definition and management of anaphylaxis: summary report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium". The Journal of Allergy and Clinical Immunology. 117 (2): 391–7. doi: 10.1016/j.jaci.2005.12.1303 . PMID   16461139.
  5. 1 2 Tintinalli, Judith E. (2010). Emergency Medicine: A Comprehensive Study Guide (Emergency Medicine (Tintinalli)). New York: McGraw-Hill Companies. pp. 177–182. ISBN   978-0-07-148480-0.
  6. 1 2 3 4 5 6 7 NHS (29 November 2019). "Overview – Anaphylaxis". NHS (National Health Service). United Kingdom: British government. Retrieved 4 March 2022.
  7. 1 2 3 4 5 6 7 Khan BQ, Kemp, SF (August 2011). "Pathophysiology of anaphylaxis". Current Opinion in Allergy and Clinical Immunology. 11 (4): 319–25. doi:10.1097/ACI.0b013e3283481ab6. PMID   21659865. S2CID   6810542.
  8. 1 2 3 4 5 6 7 8 9 10 11 12 The EAACI Food Allergy and Anaphylaxis Guidelines Group (August 2014). "Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology". Allergy. 69 (8): 1026–45. doi:10.1111/all.12437. PMID   24909803. S2CID   11054771.
  9. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 Lee JK, Vadas, P (July 2011). "Anaphylaxis: mechanisms and management". Clinical and Experimental Allergy. 41 (7): 923–38. doi:10.1111/j.1365-2222.2011.03779.x. PMID   21668816. S2CID   13218854.
  10. ↑ Ma L, Danoff TM, Borish L (April 2014). "Case fatality and population mortality associated with anaphylaxis in the United States". The Journal of Allergy and Clinical Immunology. 133 (4): 1075–83. doi:10.1016/j.jaci.2013.10.029. PMC   3972293 . PMID   24332862.
  11. ↑ Gylys B (2012). Medical Terminology Systems: A Body Systems Approach. F.A. Davis. p. 269. ISBN   9780803639133. Archived from the original on 2016-02-05.
  12. ↑ Oswalt ML, Kemp SF (May 2007). "Anaphylaxis: office management and prevention". Immunol Allergy Clin North Am. 27 (2): 177–91, vi. doi:10.1016/j.iac.2007.03.004. PMID   17493497. Clinically, anaphylaxis is considered likely to be present if any one of three criteria is satisfied within minutes to hours
  13. 1 2 3 4 5 6 7 8 9 10 11 12 13 Marx J (2010). Rosen's emergency medicine: concepts and clinical practice 7th edition. Philadelphia, PA: Mosby/Elsevier. pp. 1511–1528. ISBN   978-0-323-05472-0.
  14. 1 2 3 4 5 6 Simons FE (October 2009). "Anaphylaxis: Recent advances in assessment and treatment". The Journal of Allergy and Clinical Immunology. 124 (4): 625–36, quiz 637–8. doi:10.1016/j.jaci.2009.08.025. PMID   19815109.
  15. 1 2 3 Limsuwan T, Demoly, P (July 2010). "Acute symptoms of drug hypersensitivity (urticaria, angioedema, anaphylaxis, anaphylactic shock)" (PDF). The Medical Clinics of North America. 94 (4): 691–710, x. doi:10.1016/j.mcna.2010.03.007. PMID   20609858. Archived from the original (PDF) on 2012-04-26. Retrieved 2011-12-09.
  16. 1 2 3 4 5 6 Brown SG, Mullins, RJ, Gold, MS (Sep 4, 2006). "Anaphylaxis: diagnosis and management". The Medical Journal of Australia. 185 (5): 283–9. doi:10.5694/j.1326-5377.2006.tb00563.x. hdl: 2440/23292 . PMID   16948628. S2CID   39009649.
  17. 1 2 3 4 5 Triggiani M, Patella, V, Staiano, RI, Granata, F, Marone, G (September 2008). "Allergy and the cardiovascular system". Clinical and Experimental Immunology. 153 Suppl 1 (s1): 7–11. doi:10.1111/j.1365-2249.2008.03714.x. PMC   2515352 . PMID   18721322.
  18. 1 2 3 4 5 6 7 Boden SR, Wesley Burks, A (July 2011). "Anaphylaxis: a history with emphasis on food allergy". Immunological Reviews. 242 (1): 247–57. doi:10.1111/j.1600-065X.2011.01028.x. PMC   3122150 . PMID   21682750., citing May CD, "The ancestry of allergy: being an account of the original experimental induction of hypersensitivity recognizing the contribution of Paul Portier", J Allergy Clin Immunol. 1985 Apr; 75(4):485–495.
  19. ↑ Worm M (2010). "Epidemiology of anaphylaxis". Anaphylaxis. Chemical Immunology and Allergy. Vol. 95. pp. 12–21. doi:10.1159/000315935. ISBN   978-3-8055-9441-7. PMID   20519879.
  20. 1 2 Gausche-Hill M, Fuchs S, Yamamoto L (2007). The pediatric emergency medicine resource (Rev. 4. ed.). Sudbury, Mass.: Jones & Bartlett. p. 69. ISBN   978-0-7637-4414-4. Archived from the original on 2016-12-23.
  21. ↑ Feldweg AM (May 2015). "Exercise-Induced Anaphylaxis". Immunology and Allergy Clinics of North America (Review). 35 (2): 261–75. doi:10.1016/j.iac.2015.01.005. PMID   25841550.
  22. 1 2 3 Pravettoni V, Incorvaia C (2016). "Diagnosis of exercise-induced anaphylaxis: current insights". Journal of Asthma and Allergy. 9: 191–198. doi: 10.2147/JAA.S109105 . PMC   5089823 . PMID   27822074.
  23. 1 2 Stevens W, Buchheit K, Cahill KN (December 2015). "Aspirin-Exacerbated Diseases: Advances in Asthma with Nasal Polyposis, Urticaria, Angioedema, and Anaphylaxis". Curr Allergy Asthma Rep. 15 (12): 69. doi:10.1007/s11882-015-0569-2. PMID   26475526. S2CID   2827520.
  24. 1 2 Cardet JC, White AA, Barrett NA, Feldweg AM, Wickner PG, Savage J, Bhattacharyya N, Laidlaw TM (2014). "Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease". J Allergy Clin Immunol Pract. 2 (2): 208–213. doi:10.1016/j.jaip.2013.12.003. PMC   4018190 . PMID   24607050.
  25. ↑ Dewachter P, Mouton-Faivre, C, Emala, CW (November 2009). "Anaphylaxis and anesthesia: controversies and new insights". Anesthesiology. 111 (5): 1141–50. doi: 10.1097/ALN.0b013e3181bbd443 . PMID   19858877.
  26. 1 2 Castells MC (2010). Anaphylaxis and hypersensitivity reactions. New York: Humana Press. p. 223. ISBN   978-1-60327-950-5. Archived from the original on 2016-12-23.
  27. ↑ Stratton K, Ford A, Rusch E, Clayton EW, Committee to Review Adverse Effects of Vaccines, Institute of Medicine (2011). Adverse Effects of Vaccines: Evidence and Causality (PDF). U.S. Institute of Medicine. ISBN   9780309214353. PMID   24624471. Archived from the original on 2017-09-08. Retrieved 2014-01-16.
  28. 1 2 Simons FE, Ebisawa M, Sanchez-Borges M, Thong BY, Worm M, Tanno LK, Lockey RF, El-Gamal YM, Brown SG, Park HS, Sheikh A (2015). "2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines". The World Allergy Organization Journal. 8 (1): 32. doi: 10.1186/s40413-015-0080-1 . PMC   4625730 . PMID   26525001.
  29. ↑ Modena B, White AA, Woessner KM (November 2017). "Aspirin and Nonsteroidal Antiinflammatory Drugs Hypersensitivity and Management". Immunology and Allergy Clinics of North America. 37 (4): 727–749. doi:10.1016/j.iac.2017.07.008. PMID   28965637.
  30. 1 2 Drain KL, Volcheck, GW (2001). "Preventing and managing drug-induced anaphylaxis". Drug Safety. 24 (11): 843–53. doi:10.2165/00002018-200124110-00005. PMID   11665871. S2CID   24840296.
  31. ↑ Klotz JH, Dorn, PL, Logan, JL, Stevens, L, Pinnas, JL, Schmidt, JO, Klotz, SA (Jun 15, 2010). ""Kissing bugs": potential disease vectors and cause of anaphylaxis". Clinical Infectious Diseases. 50 (12): 1629–34. doi: 10.1086/652769 . PMID   20462351.
  32. ↑ Brown SG, Wu Q, Kelsall GR, Heddle RJ, Baldo BA (2001). "Fatal anaphylaxis following jack jumper ant sting in southern Tasmania". Medical Journal of Australia. 175 (11): 644–647. doi:10.5694/j.1326-5377.2001.tb143761.x. PMID   11837875. S2CID   2495334. Archived from the original on 2012-01-14.
  33. ↑ Bilò MB (July 2011). "Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment". Allergy. 66 (Suppl 95): 35–7. doi:10.1111/j.1398-9995.2011.02630.x. PMID   21668850. S2CID   31238581.
  34. ↑ Cox L, Larenas-Linnemann, D, Lockey, RF, Passalacqua, G (March 2010). "Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System". The Journal of Allergy and Clinical Immunology. 125 (3): 569–74, 574.e1–574.e7. doi: 10.1016/j.jaci.2009.10.060 . PMID   20144472.
  35. ↑ Bilò BM, Bonifazi, F (August 2008). "Epidemiology of insect-venom anaphylaxis". Current Opinion in Allergy and Clinical Immunology. 8 (4): 330–7. doi:10.1097/ACI.0b013e32830638c5. PMID   18596590. S2CID   28384693.
  36. ↑ Lewis JM, Cruse RE (2010). Atlas of immunology (3rd ed.). Boca Raton, FL: CRC Press/Taylor & Francis. p. 411. ISBN   9781439802694. Archived from the original on 2017-03-20.
  37. 1 2 3 Shaker MS, Wallace DV, Golden DK, Oppenheimer J, Bernstein JA, Campbell RL, Dinakar C, Ellis A, Greenhawt M, Khan DA, Lang DM, Lang ES, Lieberman JA, Portnoy J, Rank MA, Stukus DR, Wang J, Riblet N, Bobrownicki AP, Bontrager T, Dusin J, Foley J, Frederick B, Fregene E, Hellerstedt S, Hassan F, Hess K, Horner C, Huntington K, Kasireddy P, Keeler D, Kim B, Lieberman P, Lindhorst E, McEnany F, Milbank J, Murphy H, Pando O, Patel AK, Ratliff N, Rhodes R, Robertson K, Scott H, Snell A, Sullivan R, Trivedi V, Wickham A, Shaker MS, Wallace DV, Shaker MS, Wallace DV, Bernstein JA, Campbell RL, Dinakar C, Ellis A, Golden DK, Greenhawt M, Lieberman JA, Rank MA, Stukus DR, Wang J, Shaker MS, Wallace DV, Golden DK, Bernstein JA, Dinakar C, Ellis A, Greenhawt M, Horner C, Khan DA, Lieberman JA, Oppenheimer J, Rank MA, Shaker MS, Stukus DR, Wang J (April 2020). "Anaphylaxis-a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis". J Allergy Clin Immunol. 145 (4): 1082–1123. doi: 10.1016/j.jaci.2020.01.017 . PMID   32001253.
  38. 1 2 3 Lieberman P (September 2005). "Biphasic anaphylactic reactions". Ann. Allergy Asthma Immunol. 95 (3): 217–26, quiz 226, 258. doi:10.1016/S1081-1206(10)61217-3. PMID   16200811.
  39. 1 2 3 4 Ring J, Behrendt, H, de Weck, A (2010). History and classification of anaphylaxis (PDF). Chemical Immunology and Allergy. Vol. 95. pp. 1–11. doi:10.1159/000315934. ISBN   978-3-8055-9441-7. PMID   20519878.
  40. ↑ Anaphylaxis at eMedicine
  41. 1 2 Da Broi U, Moreschi, C (Jan 30, 2011). "Post-mortem diagnosis of anaphylaxis: A difficult task in forensic medicine". Forensic Science International. 204 (1–3): 1–5. doi:10.1016/j.forsciint.2010.04.039. PMID   20684869.
  42. ↑ Simons FE, Ardusso LR, Dimov V, Ebisawa M, El-Gamal YM, Lockey RF, Sanchez-Borges M, Senna GE, Sheikh A, Thong BY, Worm M, World Allergy O (2013). "World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base". International Archives of Allergy and Immunology. 162 (3): 193–204. doi: 10.1159/000354543 . PMID   24008815.
  43. ↑ Simons FE (2010). "Anaphylaxis". The Journal of Allergy and Clinical Immunology. Elsevier BV. 125 (2): S161–S181. doi: 10.1016/j.jaci.2009.12.981 . ISSN   0091-6749. PMID   20176258.
  44. ↑ Shaker MS, Wallace DV, Golden DB, Oppenheimer J, Bernstein JA, Campbell RL, Dinakar C, Ellis A, Greenhawt M, Khan DA, Lang DM, Lang ES, Lieberman JA, Portnoy J, Rank MA (April 2020). "Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis". Journal of Allergy and Clinical Immunology. 145 (4): 1082–1123. doi: 10.1016/j.jaci.2020.01.017 . PMID   32001253. S2CID   215728019.
  45. ↑ "Emergency treatment of anaphylactic reactions – Guidelines for healthcare providers" (PDF). Resuscitation Council (UK). January 2008. Archived (PDF) from the original on 2008-12-02. Retrieved 2008-04-22.
  46. ↑ Simons KJ, Simons, FE (August 2010). "Epinephrine and its use in anaphylaxis: current issues". Current Opinion in Allergy and Clinical Immunology. 10 (4): 354–61. doi:10.1097/ACI.0b013e32833bc670. PMID   20543673. S2CID   205435146.
  47. ↑ Halbrich M, Mack DP, Carr S, Watson W, Kim H (2015). "CSACI position statement: epinephrine auto-injectors and children < 15 kg". Allergy, Asthma, and Clinical Immunology. 11 (1): 20. doi: 10.1186/s13223-015-0086-9 . PMC   4485331 . PMID   26131015.
  48. ↑ Nurmatov UB, Rhatigan E, Simons FE, Sheikh A (February 2014). "H2-antihistamines for the treatment of anaphylaxis with and without shock: a systematic review". Annals of Allergy, Asthma & Immunology. 112 (2): 126–31. doi:10.1016/j.anai.2013.11.010. PMID   24468252.
  49. 1 2 Sheikh A, Ten Broek V, Brown SG, Simons FE (August 2007). "H1-antihistamines for the treatment of anaphylaxis: Cochrane systematic review". Allergy. 62 (8): 830–7. doi: 10.1111/j.1398-9995.2007.01435.x . PMID   17620060. S2CID   27548046.
  50. ↑ Martelli A, Ghiglioni, D, Sarratud, T, Calcinai, E, Veehof, S, Terracciano, L, Fiocchi, A (August 2008). "Anaphylaxis in the emergency department: a paediatric perspective". Current Opinion in Allergy and Clinical Immunology. 8 (4): 321–9. doi:10.1097/ACI.0b013e328307a067. PMID   18596589. S2CID   205434577.
  51. ↑ Harris JP, Weisman MH (2007-07-26). Head and Neck Manifestations of Systemic Disease. CRC Press. pp. 325–. ISBN   978-1-4200-1756-4.
  52. 1 2 Tejedor-Alonso M A, Moro-Moro M, Múgica-García MV (2015). "Epidemiology of Anaphylaxis: Contributions From the Last 10 Years". Journal of Investigational Allergology & Clinical Immunology. 25 (3): 163–75, quiz follow 174–5. PMID   26182682.
  53. ↑ Leslie C. Grammer (2012). Patterson's Allergic Diseases (7 ed.). Lippincott Williams & Wilkins. ISBN   9781451148633. Archived from the original on 2015-06-20.
  54. ↑ Koplin JJ, Martin, PE, Allen, KJ (October 2011). "An update on epidemiology of anaphylaxis in children and adults". Current Opinion in Allergy and Clinical Immunology. 11 (5): 492–6. doi:10.1097/ACI.0b013e32834a41a1. PMID   21760501. S2CID   13164564.
  55. ↑ Fromer L (December 2016). "Prevention of Anaphylaxis: The Role of the Epinephrine Auto-Injector". The American Journal of Medicine. 129 (12): 1244–1250. doi: 10.1016/j.amjmed.2016.07.018 . PMID   27555092.
  56. ↑ Demain JG, Minaei, AA, Tracy, JM (August 2010). "Anaphylaxis and insect allergy". Current Opinion in Allergy and Clinical Immunology. 10 (4): 318–22. doi:10.1097/ACI.0b013e32833a6c72. PMID   20543675. S2CID   12112811.
  57. ↑ Shampo MA, Kyle RA (1987). "François Magendie: Early French Physiologist". Mayo Clinic Proceedings. 62 (5): 412. doi:10.1016/S0025-6196(12)65446-9. PMID   3553755.
  58. 1 2 Richet G (2003). "The discovery of anaphylaxis, a brief but triumphant encounter of two physiologists (1902)". Histoire des Sciences Médicales. 37 (4): 463–469. PMID   14989211.
  59. ↑ Dworetzky M, Cohen S, Cohen SG, Zelaya-Quesada M (2002). "Portier, Richet, and the discovery of anaphylaxis: A centennial". Journal of Allergy and Clinical Immunology. 110 (2): 331–336. doi: 10.1016/S0091-6749(02)70118-8 . PMID   12170279.
  60. 1 2 Androutsos G, Karamanou M, Stamboulis E, Liappas I, Lykouras E, Papadimitriou GN (2011). "The Nobel Prize laureate – father of anaphylaxis Charles-Robert Richet (1850–1935) and his anticancerous serum" (PDF). Journal of BUON. 16 (4): 783–786. PMID   22331744.
  61. ↑ Suput D (2011). "Interactions of Cnidarian Toxins with the Immune System". Inflammation & Allergy - Drug Targets. 10 (5): 429–437. doi:10.2174/187152811797200678. PMID   21824078.
  62. 1 2 Boden SR, Wesley Burks A (2011). "Anaphylaxis: a history with emphasis on food allergy: Anaphylaxis: a history with emphasis on food allergy". Immunological Reviews. 242 (1): 247–257. doi:10.1111/j.1600-065X.2011.01028.x. PMC   3122150 . PMID   21682750.
  63. ↑ May CD (1985). "The ancestry of allergy: Being an account of the original experimental induction of hypersensitivity recognizing the contribution of Paul Portier". Journal of Allergy and Clinical Immunology. 75 (4): 485–495. doi: 10.1016/S0091-6749(85)80022-1 . PMID   3884689.
  64. ↑ "anaphylaxis". merriam-webster.com. Archived from the original on 2010-04-10. Retrieved 2009-11-21.
  65. ↑ "De l'action anaphylactique de certains venins | Association des amis de la Bibliothèque nationale de France". sciences.amisbnf.org. Retrieved 2022-06-24.
  66. 1 2 Ring J, Grosber M, Brockow K, Bergmann K (2014), Bergmann K, Ring J (eds.), "Anaphylaxis", Chemical Immunology and Allergy, S. Karger AG, 100: 54–61, doi: 10.1159/000358503 , ISBN   978-3-318-02194-3, PMID   24925384 , retrieved 2022-06-24
  67. ↑ Richet G, Estingoy P (2003). "The life and times of Charles Richet". Histoire des Sciences Médicales. 37 (4): 501–513. ISSN   0440-8888. PMID   15025138.
  68. ↑ "Aquestive Therapeutics Successfully Demonstrates Repeatable and Predictable Oral Sublingual Film Administration of Epinephrine". Aquestive. 2021-03-25. Retrieved 2021-12-01.
  69. ↑ Vichyanond P (September 2011). "Omalizumab in allergic diseases, a recent review". Asian Pacific Journal of Allergy and Immunology. 29 (3): 209–19. PMID   22053590.
Tango Phone medapp.svg
Wikipedia's health care articles can be viewed offline with the Medical Wikipedia app .

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.